-transparent.png){kind=logo}
ITP is the most common autoimmune disease during pregnancy. Whereas the maternal risk due to the extreme thrombocytopenia can be calculated, the risk to the foetus is difficult to predict. As there is no correlation between maternal and foetal platelet count, no generalisations can be made as to the preferable method of delivery. The methods of treatment with special reference to pregnancy and the various procedures necessary during delivery are discussed.
Related Publications
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
May 1999,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
March 1986,
Orvosi hetilap,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
March 1969,
Lakartidningen,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
July 1975,
Josanpu zasshi = The Japanese journal for midwife,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
October 1976,
Srpski arhiv za celokupno lekarstvo,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
January 1991,
Acta haematologica Polonica,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
January 2013,
BMJ case reports,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
April 1987,
Nederlands tijdschrift voor geneeskunde,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
March 2002,
Blood reviews,
R Knitza, and
J Wisser, and
M Mempel, and
E Hiller
February 1994,
The Journal of the Association of Physicians of India,
